Typhoid Fever Complications
Life-Threatening Complications
The most critical complications of typhoid fever are intestinal perforation and gastrointestinal bleeding, which typically occur in the third week of untreated disease and carry mortality rates of 5-80% in resource-poor settings. 1
Intestinal Perforation
- Occurs in 0.8% to 39% of typhoid cases, with striking differences between high-income and low-middle-income countries 1
- Most commonly affects the ileum or jejunum 2
- Presents with severe abdominal pain, signs of peritonitis, and potential septic shock 2
- Requires immediate surgical intervention, though outcomes are heavily dependent on timing of surgery and availability of intensive care 1
- Mortality remains unacceptably high (5-80%) in developing countries due to delayed diagnosis, difficult transport to facilities, and inadequate postoperative care 1
Gastrointestinal Bleeding
- Represents another major intestinal complication that can be life-threatening 2
- May occur concurrently with or independently of perforation 1
Neurological Complications
- Encephalopathy occurs as a rare but serious complication 2
- Presents with confusion, seizures, or reduced Glasgow coma scale 3
- May indicate cerebral malaria as a differential or hypoglycemia in the context of severe sepsis 3
Septic Shock
- Can develop in severe cases, particularly with delayed treatment 2
- Requires immediate empiric antibiotic therapy after blood culture collection 2
Treatment Approach
First-Line Antibiotic Selection
For patients from South Asia (particularly India, Pakistan, Bangladesh), azithromycin 500 mg once daily for 14 days is the preferred treatment due to widespread fluoroquinolone resistance exceeding 70% in this region. 4, 5
- Over 70% of S. typhi isolates from Asia demonstrate fluoroquinolone resistance, making empiric ciprofloxacin inappropriate 4
- Azithromycin has a relapse rate of less than 3%, superior to other agents 4
- The 14-day treatment duration must be completed regardless of fever resolution to prevent relapse 4
Alternative Agents Based on Geography and Severity
For severe cases requiring parenteral therapy or when azithromycin is unavailable, ceftriaxone 1-2g IV/IM daily for 14 days is the appropriate alternative. 4, 2
- All isolates in recent studies remained susceptible to third-generation cephalosporins 5
- Ceftriaxone may have higher relapse rates than azithromycin, particularly with shorter treatment courses 4
- Clinical improvement should occur within 4-5 days of appropriate therapy 4
For patients from sub-Saharan Africa where fluoroquinolone resistance is less common, ciprofloxacin remains an option if nalidixic acid sensitivity is confirmed. 3, 4
- Fluoroquinolones have relapse rates less than 8% when organisms are sensitive 4
- Ciprofloxacin disc testing is unreliable; only use fluoroquinolones if nalidixic acid sensitivity is documented 4
Critical Treatment Pitfalls to Avoid
- Never discontinue antibiotics when fever clears - this is the most common cause of relapse; complete the full 14-day course 4
- Never use empiric ciprofloxacin for patients from South Asia - resistance exceeds 70% in this population 4, 5
- Never use cefixime as first-line therapy - it has documented relapse rates of 4-37.6% and higher clinical failure rates compared to other agents 4, 6
Diagnostic Confirmation
- Blood culture is the gold standard with 40-80% sensitivity in the first week of symptoms 4, 2
- Obtain blood cultures immediately before starting antibiotics 4
- Bone marrow culture has higher sensitivity (35-65%) if blood cultures are negative 4
- The Widal test alone is insufficient for diagnosis and should not guide treatment decisions 2, 7
Monitoring for Complications
- Monitor daily for signs of intestinal perforation: severe abdominal pain, peritoneal signs, sudden clinical deterioration 2, 1
- Watch for signs of gastrointestinal bleeding: melena, hematemesis, dropping hemoglobin 1
- Assess for neurological complications: altered mental status, seizures, confusion 3, 2
- Expect fever clearance within 4-5 days of appropriate therapy; persistent fever beyond this suggests complications or treatment failure 4
Special Populations at Higher Risk
- Younger patients (particularly children and adolescents) appear at greater risk of acquiring infection and developing complications 5
- VFR (visiting friends and relatives) travelers to South Asia represent the highest-risk group 5, 8
- Immunocompromised individuals, those with chronic liver disease, and malnourished children face increased risk of severe disease 2
Prevention Strategies
- Oral Ty21a vaccine provides protection with booster every 5 years for high-risk individuals 4
- Vaccination is not a substitute for careful food and water selection 3, 4
- Hand hygiene and avoiding high-risk foods remain essential preventive measures 4
- Pre-travel vaccination should be targeted at VFR travelers to South Asia where risk exceeds 100 cases per 100,000 person-years 3, 5